Subtopic Deep Dive

Complement Genetics
Research Guide

What is Complement Genetics?

Complement Genetics studies genetic variants and copy number variations in complement system genes associated with diseases including age-related macular degeneration (AMD), atypical hemolytic uremic syndrome (aHUS), cystic fibrosis, and infectious disease severity.

Researchers identify rare variants in genes like C3 and MBL2 through GWAS and functional genomics. Key findings link C3 variants to AMD risk (Yates et al., 2007, 823 citations) and MBL polymorphisms to cystic fibrosis lung severity (Garred et al., 1999, 433 citations). Over 10 high-citation papers map these associations across immune-mediated conditions.

Curated Papers

Key Challenges

Why It Matters

Complement genetics identifies pleiotropic effects of variants like C3 polymorphisms in AMD (Yates et al., 2007) and MBL deficiencies increasing infection susceptibility (Eisen and Minchinton, 2003; Garred et al., 1999). These insights enable polygenic risk scores for diseases such as schizophrenia and COVID-19 severity. Therapeutic targeting of complement regulators, informed by genetic data, advances treatments for aHUS (Loirat and Frémeaux-Bacchi, 2011).

Key Research Challenges

Rare Variant Detection

Identifying low-frequency complement gene variants requires large cohorts and sensitive sequencing. GWAS struggles with rare alleles in heterogeneous diseases like AMD (Yates et al., 2007). Functional validation remains limited.

Pleiotropy Across Diseases

Same variants like MBL polymorphisms affect multiple conditions from cystic fibrosis to infections (Garred et al., 1999; Eisen and Minchinton, 2003). Disentangling tissue-specific effects challenges risk prediction. Copy number variations add complexity.

Functional Genomics Gaps

Linking genetic variants to complement pathway dysregulation needs in vitro assays. Studies on C3 variants highlight pathogenesis but lack mechanistic depth (Yates et al., 2007). Integrating epigenetics is underexplored.

Essential Papers

Complement System Part I â€“ Molecular Mechanisms of Activation and Regulation

Nicolas S. Merle, S. Church, Véronique Frémeaux‐Bacchi et al. · 2015 · Frontiers in Immunology · 1.5K citations

Complement is a complex innate immune surveillance system, playing a key role in defense against pathogens and in host homeostasis. The complement system is initiated by conformational changes in r...

Complement System Part II: Role in Immunity

Nicolas S. Merle, Rémi Noé, Lise Halbwachs‐Mecarelli et al. · 2015 · Frontiers in Immunology · 988 citations

International audience

Complement C3 Variant and the Risk of Age-Related Macular Degeneration

John R.W. Yates, Tiina Sepp, Baljinder K. Matharu et al. · 2007 · New England Journal of Medicine · 823 citations

Complement C3 is important in the pathogenesis of age-related macular degeneration. This finding further underscores the influence of the complement pathway in the pathogenesis of this disease.

Atypical hemolytic uremic syndrome

Chantal Loirat, Véronique Frémeaux‐Bacchi · 2011 · Orphanet Journal of Rare Diseases · 648 citations

Complement component C3 – The “Swiss Army Knife” of innate immunity and host defense

Daniel Ricklin, Edimara S. Reis, Dimitrios C. Mastellos et al. · 2016 · Immunological Reviews · 495 citations

Summary As a preformed defense system, complement faces a delicate challenge in providing an immediate, forceful response to pathogens even at first encounter, while sparing host cells in the proce...

Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis

Peter Garred, Tacjana Pressler, Hans O. Madsen et al. · 1999 · Journal of Clinical Investigation · 433 citations

Mannose-binding lectin (MBL) is a key factor in innate immunity, and lung infections are the leading cause of morbidity and mortality in cystic fibrosis (CF). Accordingly, we investigated whether M...

Impact of Mannose-Binding Lectin on Susceptibility to Infectious Diseases

Damon P. Eisen, R. M. Minchinton · 2003 · Clinical Infectious Diseases · 429 citations

When the adaptive immune response is either immature or compromised, the innate immune system constitutes the principle defense against infection. Mannose-binding lectin (MBL) is a C-type serum lec...

Reading Guide

Foundational Papers

Start with Yates et al. (2007) for C3-AMD link (823 citations), Garred et al. (1999) for MBL in CF (433 citations), and Loirat and Frémeaux-Bacchi (2011) for aHUS genetics (648 citations) to grasp core variant-disease associations.

Recent Advances

Merle et al. (2015, Part I/II, 1480/988 citations) detail molecular regulation; Ricklin et al. (2016, 495 citations) on C3 functions; Morgan and Harris (2015, 416 citations) on therapeutic targets.

Core Methods

GWAS for common variants (Yates et al., 2007); genotyping for MBL polymorphisms (Garred et al., 1999); functional assays for pathway activation (Roos et al., 2001).

How PapersFlow Helps You Research Complement Genetics

Discover & Search

Research Agent uses searchPapers and citationGraph to map C3 variant literature from Yates et al. (2007), revealing 823 citations and clusters in AMD genetics. exaSearch uncovers MBL2 studies in infectious diseases; findSimilarPapers expands from Garred et al. (1999) to pleiotropy networks.

Analyze & Verify

Analysis Agent applies readPaperContent to extract variant data from Loirat and Frémeaux-Bacchi (2011) on aHUS, then verifyResponse with CoVe checks claims against 250M+ papers. runPythonAnalysis performs GWAS statistical tests on extracted allele frequencies; GRADE grading scores evidence strength for MBL deficiency risks.

Synthesize & Write

Synthesis Agent detects gaps in pleiotropic effects across AMD and infections, flagging contradictions between Yates et al. (2007) and Garred et al. (1999). Writing Agent uses latexEditText, latexSyncCitations for genetic pathway diagrams, and latexCompile for manuscripts; exportMermaid visualizes variant-disease networks.

Use Cases

"Statistical association of MBL variants with cystic fibrosis outcomes?"

Research Agent → searchPapers('MBL cystic fibrosis') → Analysis Agent → runPythonAnalysis (pandas odds ratio calculation on Garred et al. 1999 data) → CSV export of p-values and risk estimates.

"Compile review on C3 genetics in AMD with figures?"

Synthesis Agent → gap detection → Writing Agent → latexGenerateFigure (complement pathway) + latexSyncCitations (Yates et al. 2007) → latexCompile → PDF with cited variant diagrams.

"Find code for complement GWAS analysis?"

Research Agent → paperExtractUrls (from recent genetics papers) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for rare variant burden testing.

Automated Workflows

Deep Research workflow scans 50+ papers on complement variants, chaining citationGraph from Yates et al. (2007) to structured polygenic risk report. DeepScan's 7-step analysis verifies MBL pleiotropy claims (Garred et al., 1999) with CoVe checkpoints and GRADE scoring. Theorizer generates hypotheses on CNVs in schizophrenia from AMD genetics clusters.

Try Doxa for Complement Genetics Research

Frequently Asked Questions

What is Complement Genetics?

Complement Genetics examines variants in genes like C3 and MBL2 linked to diseases such as AMD and aHUS. Key example: C3 variant raises AMD risk (Yates et al., 2007).

What methods identify complement variants?

GWAS and sequencing detect polymorphisms; functional assays validate effects. Studies use cohort genotyping for MBL in infections (Eisen and Minchinton, 2003).

What are key papers?

Yates et al. (2007, 823 citations) on C3 in AMD; Garred et al. (1999, 433 citations) on MBL in cystic fibrosis; Loirat and Frémeaux-Bacchi (2011, 648 citations) on aHUS.